Literature DB >> 2813370

Molecular definition of bovine argininosuccinate synthetase deficiency.

J A Dennis1, P J Healy, A L Beaudet, W E O'Brien.   

Abstract

Citrullinemia is an inborn error of metabolism due to deficiency of the urea cycle enzyme, argininosuccinate synthetase [L-citrulline:L-aspartate ligase (AMP-forming), EC 6.3.4.5]. The disease was first described in humans but was recently reported in dairy cattle in Australia. Here we report the nucleotide sequence of the normal bovine cDNA for argininosuccinate synthetase and the mutation present in animals with citrullinemia. Analysis of DNA from affected animals by Southern blotting did not readily identify the mutation in the bovine gene. RNA (Northern) blotting revealed a major reduction in the steady-state amount of mRNA in the liver of affected animals to less than 5% of controls. The bovine cDNA was cloned and sequenced and revealed 96% identity with the deduced human sequence at the amino acid level. Starting with mutant bovine liver, the mRNA was reverse-transcribed; the cDNA product was amplified with the polymerase chain reaction, cloned, and sequenced. The sequence revealed a C----T transition converting arginine-86 (CGA) to a nonsense codon (TGA). A second C----T transition represented a polymorphism in proline-175 (CCC----CCT). The mutation and the polymorphism were confirmed by amplification of genomic DNA and demonstration with restriction endonuclease enzymes of both the loss of an Ava II site in DNA from mutant animals at codon 86 and the presence or absence of a Dde I site at codon 175. The loss of the Ava II site can be used for rapid, economical, nonradioactive detection of heterozygotes for bovine citrullinemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813370      PMCID: PMC298189          DOI: 10.1073/pnas.86.20.7947

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Biosynthesis of urea. VII. Reversible formation of argininosuccinic acid.

Authors:  B PETRACK; S RATNER
Journal:  J Biol Chem       Date:  1958-12       Impact factor: 5.157

2.  Biosynthesis of urea. IV. Further studies on condensation in arginine synthesis from citrulline.

Authors:  S RATNER; B PETRACK
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

3.  Nucleotide sequence of the cDNA encoding the rat argininosuccinate synthetase.

Authors:  L C Surh; S M Morris; W E O'Brien; A L Beaudet
Journal:  Nucleic Acids Res       Date:  1988-10-11       Impact factor: 16.971

4.  New amber mutation in a beta-thalassemic gene with nonmeasurable levels of mutant messenger RNA in vivo.

Authors:  G F Atweh; H E Brickner; X X Zhu; H H Kazazian; B G Forget
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

5.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

6.  A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.

Authors:  M R Kuehn; A Bradley; E J Robertson; M J Evans
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

7.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells.

Authors:  M Hooper; K Hardy; A Handyside; S Hunter; M Monk
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

9.  Premature translation termination mediates triosephosphate isomerase mRNA degradation.

Authors:  I O Daar; L E Maquat
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

10.  Extensive DNA polymorphism at the factor XIIIa (F13A) locus and linkage to HLA.

Authors:  H Y Zoghbi; S P Daiger; A McCall; W E O'Brien; A L Beaudet
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

View more
  21 in total

1.  Gene therapy for metabolic disorders: an overview with a focus on urea cycle disorders.

Authors:  Ian E Alexander; Cindy Kok; Allison P Dane; Sharon C Cunningham
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

2.  Lack of carriers of citrullinaemia and DUMPS in Indian Holstein cattle.

Authors:  Rajesh K Patel; Krishna M Singh; Kalpesh J Soni; Jenabhai B Chauhan; Krothapalli R S Sambasiva Rao
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

Review 3.  Induced pluripotent stem cells from farm animals.

Authors:  Yue Su; Jiaqi Zhu; Saleh Salman; Young Tang
Journal:  J Anim Sci       Date:  2020-11-01       Impact factor: 3.159

4.  Hepatocyte gene therapy in a large animal: a neonatal bovine model of citrullinemia.

Authors:  B Lee; J A Dennis; P J Healy; B Mull; L Pastore; H Yu; E Aguilar-Cordova; W O'Brien; P Reeds; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Molecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complex.

Authors:  J L Chuang; C R Fisher; R P Cox; D T Chuang
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

6.  Spectrum of small mutations in the dystrophin coding region.

Authors:  T W Prior; C Bartolo; D K Pearl; A C Papp; P J Snyder; M S Sedra; A H Burghes; J R Mendell
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

7.  Screening for bovine leukocyte adhesion deficiency, deficiency of uridine monophosphate synthase, complex vertebral malformation, bovine citrullinaemia, and factor XI deficiency in Holstein cows reared in Turkey.

Authors:  Hasan Meydan; Mehmet A Yildiz; Jørgen S Agerholm
Journal:  Acta Vet Scand       Date:  2010-10-07       Impact factor: 1.695

8.  Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle.

Authors:  D E Shuster; M E Kehrli; M R Ackermann; R O Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Evaluation of gene therapy for citrullinaemia using murine and bovine models.

Authors:  G Patejunas; B Lee; J A Dennis; P J Healy; P J Reeds; H Yu; M Frazer; B Mull; A W Warman; A L Beaudet; W E O'Brien
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

10.  Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia.

Authors:  K Kobayashi; N Shaheen; H Terazono; T Saheki
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.